Internal Medicine, Endocrinology, Diabetes, & Metabolism · Akron, OH
NPI
1366730418
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
444 N Main St Ste 306
Akron, OH, 44310
Phone (330) 379-5048
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
573 services
Medicare patients, 2024
134
Average age 72
Drug cost, 2024
$1.5M
3,093 prescriptions
Company payments, 2024
$18.98
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nathan J McCartney was code 99214 (office e&m - established), 334 times for 124 patients. In total Nathan J McCartney billed 573 services in 7 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 334 | 124 | $55.92 | $19K |
| 95251 Test - Miscellaneous | Office | 194 | 77 | $20.34 | $3,945 |
| 99213 Office E&M - Established | Office | 24 | 18 | $47.43 | $1,138 |
By year: 2022 $23K for 490 services; 2023 $24K for 526 services; 2024 $25K for 573 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nathan J McCartney prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 244 prescriptions and refills. In total Nathan J McCartney wrote 3,093 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Er Metformin Hcl | 244 | 643 | 65 | $1,892 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 231 | 584 | 70 | $44K |
| Metformin Hcl Generic | 230 | 533 | 55 | $1,366 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 174 | 378 | 41 | $164K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 172 | 434 | 64 | $20K |
| Glimepiride Generic | 152 | 356 | 41 | $779 |
| Trulicity Dulaglutide | 140 | 204 | 34 | $195K |
| Mounjaro Tirzepatide | 136 | 136 | 16 | $139K |
| Humalog Kwikpen U-100 Insulin Lispro | 117 | 292 | 42 | $49K |
| Ozempic Semaglutide | 99 | 179 | 32 | $167K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 93 | 239 | 42 | $13K |
| Novolog Flexpen Insulin Aspart | 83 | 173 | 31 | $21K |
| Tresiba Flextouch U-100 Insulin Degludec | 74 | 217 | 25 | $48K |
| Tresiba Flextouch U-200 Insulin Degludec | 62 | 103 | 13 | $74K |
| Glipizide Generic | 56 | 137 | 12 | $314 |
Brand drugs: 1,749 claims; generic drugs: 801 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Nathan J McCartney $18.98 ($18.98 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $18.98.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $18.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.